Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	190.06	98.78	24.95	120.23	178.66	77.07
Cash & Short-Term Investments	190.06	98.78	24.95	120.23	178.66	77.07
Cash Growth	573.17%	295.93%	-79.25%	-32.70%	131.82%	585.11%
Accounts Receivable	3.48	3.68	-	-	-	-
Other Receivables	1.89	4.13	0.2	-	-	-
Receivables	5.37	7.82	0.2	-	-	-
Inventory	5.73	8.41	14.15	-	-	-
Prepaid Expenses	3.72	2.45	6.25	9.32	9.21	9.26
Other Current Assets	3.2	1.55	2.23	1.23	1.18	1.66
Total Current Assets	208.07	119	47.77	130.78	189.05	87.99
Property, Plant & Equipment	42.95	42.82	94.85	94.53	51.47	9.83
Goodwill	-	-	0.97	-	-	-
Other Intangible Assets	0.12	0.12	9.74	0.12	-	0.12
Other Long-Term Assets	1.3	0.95	1.13	0.26	0.38	0.25
Total Assets	252.44	162.89	154.46	225.69	240.9	98.18
Accounts Payable	8.54	4.55	3.78	8.07	13.28	4.6
Accrued Expenses	6.04	7.01	8.74	9.68	7.95	4.63
Current Portion of Long-Term Debt	-	2.82	2.35	-	-	-
Current Portion of Leases	0.16	0.27	0.27	0.43	0.49	0.6
Other Current Liabilities	6.29	3.66	3.74	-	-	-
Total Current Liabilities	21.03	18.31	18.88	18.18	21.72	9.82
Long-Term Debt	-	4.67	6.56	-	-	-
Long-Term Leases	0.27	0.36	0.63	0.33	0.47	0.72
Other Long-Term Liabilities	-	-	22.86	-	-	-
Total Liabilities	21.3	23.33	48.93	18.51	22.18	10.54
Common Stock	0.01	0	-	0.01	0.02	0.21
Additional Paid-In Capital	1,039	870.5	706.42	677.38	578.61	355.04
Retained Earnings	-807.81	-730.69	-600.66	-470.04	-359.82	-267.53
Comprehensive Income & Other	-0.27	-0.26	-0.23	-0.17	-0.09	-0.06
Shareholders' Equity	231.14	139.56	105.53	207.18	218.72	87.65
Total Liabilities & Equity	252.44	162.89	154.46	225.69	240.9	98.18
Total Debt	0.43	8.12	9.81	0.76	0.96	1.31
Net Cash (Debt)	189.63	90.66	15.14	119.47	177.7	75.76
Net Cash Growth	870.42%	498.99%	-87.33%	-32.77%	134.57%	595.59%
Net Cash Per Share	31.01	123.12	-	-	-	-
Filing Date Shares Outstanding	11.78	6.43	0.03	-	-	-
Total Common Shares Outstanding	10.17	4.39	0.02	-	-	-
Working Capital	187.04	100.7	28.88	112.6	167.33	78.17
Book Value Per Share	22.73	31.82	5761.04	-	-	-
Tangible Book Value	231.02	139.44	94.82	207.06	218.72	87.53
Tangible Book Value Per Share	22.72	31.79	5176.45	-	-	-
Land	8.01	8.01	8.01	8.01	7.91	5.71
Buildings	24.5	24.5	66.75	65.64	-	-
Machinery	15.25	13.5	24.27	20.33	1.1	0.39
Construction In Progress	-	-	-	1.37	41.92	2.8
Leasehold Improvements	0.03	0.03	0.03	0.03	0.02	0.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q